FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311583839> ?p ?o ?g. }

• W4311583839 abstract "Abstract Background Immune checkpoint inhibition with anti-PD(L)1 and anti-CTLA4 antibodies has significantly changed cancer treatment during the last 10 years. Nevertheless, boosting the immune system with immune checkpoint inhibition can result in immune-related adverse events, affecting different organ systems, among which the endocrine system is the most affected. However, there are few descriptions of the association of immune-related adverse events, and the pathophysiology of some is still lacking. Case summary Here, we report a 70-year-old Caucasian patient treated with nivolumab (anti-PD1 monoclonal antibody) after resection of a unique relapse of melanoma in the neck region who presented with sicca syndrome, extreme fatigue, and weight loss 6 months after the start of anti-PD1 therapy. Blood tests revealed hypoglycemia and secondary hypocortisolism due to isolated adrenocorticotrophic hormone deficiency. Interestingly, brain methionine positron emission tomography/magnetic resonance revealed physiological metabolism of the pituitary gland, which was not increased in size, and no hypophyseal metastasis was detected. The sicca syndrome investigation revealed the absence of anti-SSA/SSB antibodies, while the labial salivary gland biopsy showed lymphoplasmatocytic infiltrates with a focus score of 1. To provide new insights into the physiopathology of the anti-PD1-related sialadenitis, we investigated the distribution of aquaporins 5 by immunostaining on the labial salivary gland acini, and compared this distribution with the one expressed in the primary Sjögren’s syndrome. Contrary to patients with primary Sjögren’s syndrome (in whom aquaporins 5 is mainly expressed at the basolateral side), but similar to the patients with no sialadenitis, we observed expression of aquaporins 5 at the apical pole. This new finding deserves to be confirmed in other patients with anti-PD1-related sialadenitis. Owing to these immune-related adverse events, anti-PD1 was stopped; nevertheless, the patient developed a new relapse 1 year later (March 2020) in the neck region, which was treated by radiotherapy. Since then, no relapse of melanoma was seen (1.5 years after radiotherapy), but the patient still requires hypophyseal replacement therapy. The sialoadenitis resolved partially. Conclusion We report a combination of sialoadenitis and hypophysitis explaining extreme fatigue in a patient who was treated in the adjuvant setting with anti-PD1 for a melanoma relapse." @default.
• W4311583839 created "2022-12-27" @default.
• W4311583839 creator A5038345110 @default.
• W4311583839 creator A5043383457 @default.
• W4311583839 creator A5060295979 @default.
• W4311583839 creator A5063737641 @default.
• W4311583839 creator A5078979270 @default.
• W4311583839 creator A5084384494 @default.
• W4311583839 date "2022-12-09" @default.
• W4311583839 modified "2023-10-17" @default.
• W4311583839 title "Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab: a case report" @default.
• W4311583839 cites W1850523969 @default.
• W4311583839 cites W2059820796 @default.
• W4311583839 cites W2065856920 @default.
• W4311583839 cites W2085247907 @default.
• W4311583839 cites W2094366129 @default.
• W4311583839 cites W2103164876 @default.
• W4311583839 cites W2164903177 @default.
• W4311583839 cites W2177405394 @default.
• W4311583839 cites W2289841322 @default.
• W4311583839 cites W2368502720 @default.
• W4311583839 cites W2428806539 @default.
• W4311583839 cites W2441690768 @default.
• W4311583839 cites W2501357434 @default.
• W4311583839 cites W2582384359 @default.
• W4311583839 cites W2605754740 @default.
• W4311583839 cites W2635292439 @default.
• W4311583839 cites W2673218446 @default.
• W4311583839 cites W2754342149 @default.
• W4311583839 cites W2770182655 @default.
• W4311583839 cites W2783137027 @default.
• W4311583839 cites W2787399901 @default.
• W4311583839 cites W2802667506 @default.
• W4311583839 cites W2811334399 @default.
• W4311583839 cites W2899265350 @default.
• W4311583839 cites W2921353943 @default.
• W4311583839 cites W2921474571 @default.
• W4311583839 cites W2939131851 @default.
• W4311583839 cites W2944844408 @default.
• W4311583839 cites W2953531214 @default.
• W4311583839 cites W2962807330 @default.
• W4311583839 cites W2979569056 @default.
• W4311583839 cites W3005370270 @default.
• W4311583839 doi "https://doi.org/10.1186/s13256-022-03663-6" @default.
• W4311583839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36482425" @default.
• W4311583839 hasPublicationYear "2022" @default.
• W4311583839 type Work @default.
• W4311583839 citedByCount "1" @default.
• W4311583839 crossrefType "journal-article" @default.
• W4311583839 hasAuthorship W4311583839A5038345110 @default.
• W4311583839 hasAuthorship W4311583839A5043383457 @default.
• W4311583839 hasAuthorship W4311583839A5060295979 @default.
• W4311583839 hasAuthorship W4311583839A5063737641 @default.
• W4311583839 hasAuthorship W4311583839A5078979270 @default.
• W4311583839 hasAuthorship W4311583839A5084384494 @default.
• W4311583839 hasBestOaLocation W43115838391 @default.
• W4311583839 hasConcept C126322002 @default.
• W4311583839 hasConcept C142724271 @default.
• W4311583839 hasConcept C197934379 @default.
• W4311583839 hasConcept C203014093 @default.
• W4311583839 hasConcept C2777701055 @default.
• W4311583839 hasConcept C2778808962 @default.
• W4311583839 hasConcept C2778937882 @default.
• W4311583839 hasConcept C2780030458 @default.
• W4311583839 hasConcept C71924100 @default.
• W4311583839 hasConcept C8891405 @default.
• W4311583839 hasConceptScore W4311583839C126322002 @default.
• W4311583839 hasConceptScore W4311583839C142724271 @default.
• W4311583839 hasConceptScore W4311583839C197934379 @default.
• W4311583839 hasConceptScore W4311583839C203014093 @default.
• W4311583839 hasConceptScore W4311583839C2777701055 @default.
• W4311583839 hasConceptScore W4311583839C2778808962 @default.
• W4311583839 hasConceptScore W4311583839C2778937882 @default.
• W4311583839 hasConceptScore W4311583839C2780030458 @default.
• W4311583839 hasConceptScore W4311583839C71924100 @default.
• W4311583839 hasConceptScore W4311583839C8891405 @default.
• W4311583839 hasIssue "1" @default.
• W4311583839 hasLocation W43115838391 @default.
• W4311583839 hasLocation W43115838392 @default.
• W4311583839 hasLocation W43115838393 @default.
• W4311583839 hasOpenAccess W4311583839 @default.
• W4311583839 hasPrimaryLocation W43115838391 @default.
• W4311583839 hasRelatedWork W1975199854 @default.
• W4311583839 hasRelatedWork W1978633872 @default.
• W4311583839 hasRelatedWork W2005146943 @default.
• W4311583839 hasRelatedWork W2013874406 @default.
• W4311583839 hasRelatedWork W2019150299 @default.
• W4311583839 hasRelatedWork W2079070424 @default.
• W4311583839 hasRelatedWork W2108664124 @default.
• W4311583839 hasRelatedWork W2170691133 @default.
• W4311583839 hasRelatedWork W2472731714 @default.
• W4311583839 hasRelatedWork W3135091395 @default.
• W4311583839 hasVolume "16" @default.
• W4311583839 isParatext "false" @default.
• W4311583839 isRetracted "false" @default.
• W4311583839 workType "article" @default.